Eric Shen is the founder of Shen Strategy Consulting, LLC, established in January 2024, specializing in corporate development solutions for early-stage biotech startups. Previously, Eric served as Managing Director at Old Silver VC from April 2021 to September 2023, focusing on early-stage investments in biotech and related fields. Other notable roles include Venture Advisor at Pear Therapeutics, where Eric contributed to the approval of the first digital therapeutic, and various positions at Ohana Biosciences and Kojin Therapeutics, emphasizing strategic and operational excellence in the biotech sector. Eric currently holds the position of Chief of Staff at the T1D Fund, a mission-driven impact investment fund dedicated to advancing treatments for type 1 diabetes. Eric holds a Bachelor’s Degree from Brandeis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices